Ascendis Pharma A (ASND) EBITDA (2014 - 2026)
Ascendis Pharma A's EBITDA was $261.57 million in the quarter ended Jun 30, 2026, compared with -$54.93 million a year earlier and up 669.6% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) EBITDA (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ascendis Pharma A's EBITDA was $329.97 million through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$239.75 million.
- In earlier years, EBITDA was -$392.83 million in the year ended Dec 31, 2024, -$569.61 million in the year ended Dec 31, 2023, -$573.2 million in the year ended Dec 31, 2022 and -$499.23 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly EBITDA in data going back to the quarter ended Mar 31, 2014.
- Per Business Quant data, ASND's EBITDA in the three quarters before the quarter ended Jun 30, 2026 was $33.99 million (quarter ended Mar 31, 2026), $17.13 million (quarter ended Dec 31, 2025) and $17.28 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Ascendis Pharma A | 14.48 Bn | 10.74 Bn | 362.22 Mn | 261.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 261.57 Mn |
| Mar 31, 2026 | 33.99 Mn |
| Dec 31, 2025 | 17.13 Mn |
| Sep 30, 2025 | 17.55 Mn |
| Jun 30, 2025 | -55.06 Mn |
| Mar 31, 2025 | -104.84 Mn |
| Dec 31, 2024 | 5.19 Mn |
| Sep 30, 2024 | -101.44 Mn |
| Jun 30, 2024 | -138.78 Mn |
| Mar 31, 2024 | -48.53 Mn |
| Dec 31, 2023 | -34.04 Mn |
| Sep 30, 2023 | -141.15 Mn |
| Jun 30, 2023 | -148.30 Mn |
| Mar 31, 2023 | -149.34 Mn |
| Dec 31, 2022 | -145.64 Mn |
| Sep 30, 2022 | -141.15 Mn |
| Jun 30, 2022 | -146.72 Mn |
| Mar 31, 2022 | -138.74 Mn |
| Dec 31, 2021 | -123.90 Mn |
| Sep 30, 2021 | -109.85 Mn |
API Access
Ascendis Pharma A EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();